C61
Conditions
Interventions
Group 1: Patients with prostate cancer who recieve either an intensity-modulated radiation therapy (IMRT) or brachytherapy (HDR)
Sponsors
Universitätsklinikum Freiburg, Klinik für Strahlenheilkunde
Eligibility
Sex/Gender
Male
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: SUBSTUDY 1: Prostate cancer patients under radiation with curative intent, histologically proven PCA, cT1-3, cN0, cM0, Gleason Score 6-9, PSA <40 ng/ml. SUBSTUDY 2: Patients with primary prostate cancer of favorable-intermediate- to very-high risk after NCCN (National Comprehensive Cancer Network) histologically proven PCA, cT2a-3b (MRT, PET/CT), cN0 und cM0 (MRT, PET/CT), Gleason-Score 7-9, ECOG Performance Status 0 or 1, IPSS < 15, size of prostate = 75 ml (as of date of radiation therapy planning)
Exclusion criteria
Exclusion criteria: SUBSTUDIES 1 and 2: insufficient command of German language, patient too much distressed by his condition, acute psychosis, risk of suicide present.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Patients' expectations regarding the functions of the intended app allowing them to record their therapy-related preferences (rating-scales developed by ourselves), distress (distress thermometer) and health-related quality of life before and during radiation therapy and at follow-up (EORTC QLQ-C30, EPIC-26, IPSS25). | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of life in the ensuing course of radiation therapy (EORTC QLQ-C30, EPIC-26, IPSS25) and subjective ratings of difficulty with weighing therapy-related preferences with respect to outcomes and possible side effects (rating-scales developed by ourselves). | — |
Countries
Germany
Contacts
Public ContactConstantinos Zamboglou
Universitätsklinikum Freiburg, Klinik für Strahlenheilkunde
Outcome results
None listed